Litigation

Recent Posts

Merck Wins Defense Verdict In 2nd N.J. Fosamax Jaw Injury Trial
Posted on 19 Apr 2012 by Tom Moylan

ATLANTIC CITY, N.J. - (Mealey's) A New Jersey state court jury on April 18 returned a defense verdict for Merck, Sharpe & Dohme in a Fosamax jaw injury trial, the company said in a press release ( Jo Ann Sessner v. Merck, Sharpe & Dohme, Inc... Read More

Tags: bisphosphonate , osteonecrosis of the jaw , New Jersey , jaw injury , Merck , defense verdict , Jo Ann Sessner , Litigation , Jo Ann Sessner v. Merck Sharpe &amp , Fosamax , Dohme , osteoporosis

2nd Circuit Upholds Fosamax Bellwether Defense Verdict
Posted on 31 Jan 2013 by Tom Moylan

NEW YORK - (Mealey's) A defense verdict for Merck, Sharp & Dohme in the fourth federal Fosamax jaw injury trial was upheld Jan. 30 by the Second Circuit U.S. Court of Appeals, which found that the trial court didn't err in excluding a plaintiff... Read More

Tags: Shark & Dohme Corp. , drugs , Linda Secrest v. Merck , Second Circuit , Food and Drug Administration , osteoporosism osteonecrosis of the jawm ONJ , Expert testimony , Linda Secrest , Merck , Litigation , Fosamax , In Re: Fosamax Products Liability Litigation

Jury Awards Plaintiff $8 Million In Fosamax Lawsuit
Posted on 29 Jun 2010 by Tom Moylan

NEW YORK - (Mealey's) A jury returned an $8 million compensatory damages verdict against Merck & Co. Inc. on June 25 in the U.S. District Court for the Southern District of New York in the retrial of the first Fosamax multidistrict litigation... Read More

Tags: osteonecrosis of the jaw , Merck & Co. Inc. , personal injury , ONJ , Shirley Boles v. Merck & Co. , Litigation , multidistrict litigation , lawsuit , Shirley Boles , Fosamax , torts , osteoporosis , In Re: Fosamax Products Liability Litigation

Second Fosamax Bellwether Case Ends In Unanimous Verdict For Defendant Merck
Posted on 6 May 2010 by Tom Moylan

NEW YORK — (Mealey’s) The second federal Fosamax bellwether trial ended in a defense verdict May 6 when a jury in the U.S. District Court for the Southern District of New York unanimously found that the plaintiff did not suffer from osteonecrosis... Read More

Tags: osteonecrosis of the jaw , Louise Maley , personal injury , ONJ , Merck , Litigation , lawsuit , Fosamax , In Re: Fosamax Products Liability Litigation , torts

$8M Fosamax Verdict Remitted By MDL Judge To $1.5M Or New Damages Trial
Posted on 5 Oct 2010 by Tom Moylan

NEW YORK -- (Mealey's) The New York federal judge overseeing the Fosamax multidistrict litigation on Oct. 4 sua sponte found that an $8 million verdict in a bellwether trial is excessive and ordered a remittitur of the verdict to $1.5 million unless... Read More

Tags: Douglas & London , punitive damages , Damages , bisphosphonate , osteonecrosis of the jaw , personal injury , Judge John F. Keenan , product liability , Trial , MDL. Shirley Boles v. Merck & Co. , ONJ , Merck , Litigation , osteoporosis drug , multidistrict litigation , Fosamax multidistrict litigation , lawsuit , Shirley Boles , Fosamax , verdict , torts , Gary Douglas , In Re: Fosamax Products Liability Litigation

3rd Circuit Says Design Defect Claims For Generic Fosamax Are Preempted
Posted on 1 May 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) Strict liability design defect claims involving generic versions of the osteoporosis drug Fosamax are preempted by federal law despite plaintiffs’ attempts to narrow U.S. Supreme Court case law, a panel of the... Read More

Tags: Third Circuit , preemption , In Re: Fosamax [Alendronate Sodium] Products Liability Litigation [No. II] , Mylan Pharmaceuticals Inc. , Sun Pharmaceutical Industries Inc. , Apotex Corp. , Litigation , osteoporosis drug , multidistrict litigation , Merck Sharp & Dohme Corp. , Fosamax , U.S. Supreme Court , MDL , torts , Watson Pharmaceuticals Inc. , Teva Pharmaceuticals USA , Barr Pharmaceuticals Inc.

Merck Wins Defense Verdict In 1st Fosamax Femur Case To Go To Verdict
Posted on 1 May 2013 by Tom Moylan

TRENTON, N.J. - (Mealey's) A New Jersey federal jury on April 29 quickly found that Fosamax did not cause a plaintiff's femur fracture, the first verdict in a case in which a plaintiff claims that the osteoporosis drug weakened her thigh bone... Read More

Tags: Bernadette Glynn , New Jersey , et al. v. Merck Sharp & Dohme Corporation , In Re: Fosamax [Alendronate Sodium] Products Liability Litigation , Merck , Litigation , MDL Docket No. 08-md-00008 , osteoporosis drug , Fosamax

Merck Wins 1st State Court Fosamax Trial
Posted on 14 Feb 2011 by Tom Moylan

ATLANTIC CITY, N.J. -- The first state court trial alleging jaw injuries from Fosamax yielded a win for the defense on Feb. 14 in the Atlantic County, N.J., Superior Court ( Alison Rosenberg v. Merck, Sharpe & Dohme Corp. , No. ATL-L-3644-08, N.J... Read More

Tags: Alison Rosenberg , osteonecrosis of the jaw , personal injury , product liability , Litigation , lawsuit , Fosamax , mass tort , torts , Alison Rosenberg v. Merck Sharpe & Dohme

Fosamax Jaw Injury Claims Not Tolled By Class Action, Virginia Supreme Court Says
Posted on 5 Mar 2012 by Tom Moylan

RICHMOND, Va. - (Mealey's) Virginia does not recognize either equitable or statutory tolling for class actions brought by different plaintiffs in another jurisdiction, the Virginia Supreme Court ruled March 2 in an appeal by four Fosamax jaw injury... Read More

Tags: Virginia Supreme Court , Virginia , lawsuits , osteonecrosis of the jaw , statute of limitations , Wolfe v. Merck &amp , Fosamax jaw injury multidistrict litigation , Merck , Fosamax jaw injury , Litigation , class actions , Fosamax , John Casey , osteoporosis , John Casey v. Merck &amp

Jury Awards Plaintiff $10.4 Million For Injuries, Punitive Damages Linked To Novartis' Zometa
Posted on 5 Nov 2012 by Tom Moylan

CENTRAL ISLIP, N.Y. - (Mealey's) A New York federal jury on Nov. 2 found Novartis Pharmaceuticals Corp. liable for a woman's osteonecrosis of the jaw (ONJ) and awarded her $10.45 million, according to the parties ( Barbara Davids v. Novartis Pharmaceuticals... Read More

Tags: New York , drugs , punitive damages , osteonecrosis of the jaw , Novartis , Barbara Davids v. Novartis Pharmaceuticals Corporation , breast cancer , ONJ , bisphosphonate drug , Femara , Barbara Davids , Merck , Litigation , Fosamax , Zometa , osteoporosis

Jury Awards Plaintiff $285,000 In 5th Fosamax MDL Trial But Finds No Design Defect
Posted on 5 Feb 2013 by Tom Moylan

NEW YORK - (Mealey's) A New York federal jury on Feb. 5 ordered Novartis Pharmaceuticals Corp. to pay $285,000 to a plaintiff for allegedly failing to warn her or her doctor that Fosamax carries a risk of osteonecrosis of the jaw (ONJ) ( In Re: Fosamax... Read More

Tags: pharmaceutical litigation , osteonecrosis of the jaw , Rhoda E. Scheinberg v. Merck & Co. , ONJ , Merck , Novartis Pharmaceuticals Corp. , Litigation , multidistrict litigation , Rhonda E. Scheinberg , Fosamax , In Re: Fosamax Products Liability Litigation , Wyeth v. Levine

2nd Fosamax Bellwether Plaintiff Failed To Prove Causation, 2nd Circuit Affirms
Posted on 8 Nov 2010 by Tom Moylan

NEW YORK - (Mealey's) The second bellwether plaintiff in the Fosamax multidistrict litigation failed to produce evidence that the osteoporosis drug caused her osteonecrosis of the jaw (ONJ), a panel of the Second Circuit U.S. Court of Appeals ruled... Read More

Tags: drugs , osteonecrosis of the jaw , failure-to-warn claim , Bessie Flemings , Bessie L. Flemings v. Merck & Co. , ONJ , Fosamax MDL , e Second Circuit U.S. Court of Appeals , Litigation , multidistrict litigation , Fosamax , MDL

Jury Finds For Merck In Bellwether Fosamax Jaw Disease Trial
Posted on 22 Nov 2010 by Tom Moylan

NEW YORK - (Mealey's) A federal court jury in New York on Nov. 19 found that Merck & Co. Inc.'s osteoporosis drug Fosamax did not cause the osteonecrosis that destroyed a Florida woman's jaw ( Judith Graves v. Merck & Co. Inc. , 1... Read More

Tags: osteonecrosis , Merck & Co. Inc. , Mealey’s Emerging Drugs & Devices , osteoporosis drug , Fosamax